TY  - BOOK
ED  - United States.
TI  - Biosimilar implementation: a progress report from FDA : hearing before the Subcommittee on Primary Health and Retirement Security of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, first session, on examining biosimilar implementation, focusing on a progress report from FDA, September 17, 2015
T2  - S. hrg.
AV  - KF26 .L2774 2015a
PY  - 2017///
CY  - Washington
PB  - U.S. Government Publishing Office
KW  - United States
KW  - Food and Drug Administration
KW  - Rules and practice
KW  - fast
KW  - Pharmaceutical biotechnology
KW  - Management
KW  - Government policy
KW  - Drug development
KW  - Drugs
KW  - Generic substitution
KW  - Legislative hearings
KW  - lcgft
KW  - Rules
N1  - Shipping list no.: 2018-0124-M; CRDP Program record; Includes bibliographical references; Microfiche; [Washington, D.C.]; U.S. Government Printing Office; [2017]; 1 microfiche : negative
ER  -